FDA Market Clears Erchonia’s FX 635 Laser for Chronic Low Back Pain

Posted by & filed under Press Releases.

First and Only FDA Market Cleared Low-Level Laser Treatment Option Melbourne, FL (PRWEB) July 17, 2018 Erchonia Corporation announces another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category… Read more »